BNP Paribas Financial Markets
ACET icon

BNP Paribas Financial Markets’s Adicet Bio ACET Stock Holding History

BNP Paribas Financial Markets’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$340 Hold
50
– – ﹤0.01% 5577
2025
Q4 		$421 Sell
50
-6
-11% -$66 ﹤0.01% 5494
2025
Q3 		$726 Hold
56
– – ﹤0.01% 5270
2025
Q2 		$547 Hold
56
– – ﹤0.01% 5214
2025
Q1 		$675 Hold
56
– – ﹤0.01% 5110
2024
Q4 		$860 Buy
+56
New +$1.06K ﹤0.01% 5106
2020
Q3 		– Sell
-543
Closed -$131K – 4209
2020
Q2 		$131K Buy
543
+501
+1,193% +$98.4K ﹤0.01% 2661
2020
Q1 		$4.89K Buy
42
+26
+163% +$3.86K ﹤0.01% 4081
2019
Q4 		$2.66K Buy
16
+1
+7% +$506 ﹤0.01% 4207
2019
Q3 		$15.1K Buy
15
+6
+67% +$6.7K ﹤0.01% 4059
2019
Q2 		$9.96K Sell
9
-6
-40% -$5.44K ﹤0.01% 4102
2019
Q1 		$11.7K Buy
15
+14
+1,400% +$12.7K ﹤0.01% 4009
2018
Q4 		$793 Sell
1
-1
-50% -$1.32K ﹤0.01% 3951
2018
Q3 		$3.15K Hold
2
– – ﹤0.01% 4193
2018
Q2 		$1.9K Sell
2
-8
-80% -$8.61K ﹤0.01% 4259
2018
Q1 		$10.2K Buy
+10
New +$18.3K ﹤0.01% 4012

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BNP Paribas Financial Markets's ACET Position: Q1 2026 in Review

BNP Paribas Financial Markets held its Adicet Bio (ACET) position steady in Q1 2026 at 50 shares worth $340. The position accounts for ﹤0.01% of the portfolio, ranked #5577.

BNP Paribas Financial Markets first reported a position in ACET in Q1 2018 and has held it in 16 quarters since. The position peaked at $131K in Q2 2020. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • BNP Paribas Financial Markets held 50 shares of Adicet Bio worth $340 as of Q1 2026.
  • BNP Paribas Financial Markets left its Adicet Bio share count unchanged in Q1 2026.
  • Adicet Bio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5577 holding.
  • BNP Paribas Financial Markets first reported a position in Adicet Bio in Q1 2018 and has held it in 16 quarters since.
  • BNP Paribas Financial Markets's Adicet Bio position peaked at $131K in Q2 2020.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.